Global Antimalarial Medicines Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Antimalarial Medicines Market was valued at $1.1 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 4.4% CAGR, to an estimated market size of $1.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global antimalarial medicines market includes the development, production, and distribution of pharmaceutical therapies used for the prevention (prophylaxis) and treatment of malaria caused by Plasmodium parasites. The scope covers Artemisinin-based Combination Therapies (ACTs), quinoline derivatives, and next-generation compounds, excluding non-pharmaceutical interventions like bed nets or insecticides.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Antimalarial Medicines Market in the period 2025-30:
- The emergence of artemisinin resistance in East Africa and Southeast Asia is driving a critical shift toward Multiple First-line Treatment (MFT) strategies.
- Increased government funding and support from international organizations like the Global Fund remain the primary stabilizers for market demand in endemic regions.
- The development of next-generation compounds, such as spiroindolones, is accelerating to provide alternatives to traditional therapies facing declining efficacy.
- There is a growing clinical focus on pediatric-specific formulations, including dispersible tablets and syrups, to improve dosing accuracy for vulnerable populations.
- Integration of Artificial Intelligence (AI) and deep learning is significantly reducing the timeline for drug discovery and anti-Plasmodium property prediction.
- The expansion of digital procurement platforms is enhancing supply chain transparency and reducing the prevalence of counterfeit antimalarial drugs.
- Urban invasion by the Anopheles stephensi mosquito is altering traditional transmission patterns, necessitating new therapeutic strategies for urban environments.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- Africa
- North America
- Asia-Pacific
- Europe & Rest of World
Segments
- Artemisinin-based Combination Therapies (ACTs)
- Quinolines & Aminoquinolines
- Antifolates & Other Compounds